Daniel Loeb

Daniel Loeb

Last Update: 2014-11-14

Number of Stocks: 41
Number of New Stocks: 11

Total Value: $8,714 Mil
Q/Q Turnover: 26%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Daniel Loeb' s Profile & Performance

Profile

Daniel S. Loeb founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. He is well known for his public letters in which he criticizes company CEOs or other investment managers. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion.

Web Page:http://www.thirdpointpublic.com/

Investing Philosophy

Loeb and Third Point focus on activist investing, and follows an event-driven, value-oriented investment style. Loeb identifies situations in which a catalyst will unlock value.

Total Holding History

Performance of Master Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
201325.231.55-6.3
201221.215.45.8
2011-0.12.08-2.2
3-Year Cumulative51.6 (14.9%/year)55 (15.7%/year)-3.4 (-0.8%/year)
201033.515.0618.4
200938.226.4611.7
5-Year Cumulative179.7 (22.8%/year)125.5 (17.7%/year)54.2 (5.1%/year)
2008-32.8-374.2
200716.65.6111.0
20061515.79-0.8
200519.94.9115.0
200430.21218.2
10-Year Cumulative293.4 (14.7%/year)104.1 (7.4%/year)189.3 (7.3%/year)
200351.528.722.8
2002-7-22.115.1
200114.9-11.926.8
200017.1-9.126.2
199942.22121.2
15-Year Cumulative960.5 (17%/year)98.3 (4.7%/year)862.2 (12.3%/year)
19986.628.6-22.0
199752.133.418.7
199644.32321.3
19953737.6-0.6

Top Ranked Articles

Market Cycle Analysis & Five-Year Rolling Analysis of Guru Performance
Market Cycle Analysis In our research of John Hussman’s performance, we observed that he underperformed the market if we look at the latest 3-year annualized return, 5-year annualized return and even 10-year annualized return. Yet this might not be the case if we look at his performance over a complete economic cycle. Read more...
Dan Loeb’s Letter to the Board of Yahoo
LETTER TO THE BOARD OF DIRECTORS OF THE ISSUER Read more...
Talks of Carl Icahn Getting a Piece of Herbalife, Joining Loeb in Long Position
After fellow activist investor, Daniel Loeb set off the media earlier this week with his declaration to obtain a long position in Herbalife (HLF), a company that Pershing Square’s Bill Ackman just shorted weeks ago, corporate raiding Guru Carl Icahn has been reported yesterday afternoon of joining Loeb in taking a piece of the action. Read more...
Daniel Loeb Comments on AIG
Equity: AIG (AIG) Read more...
Why Third Point Capital's Daniel Loeb Is Beating John Paulson and David Einhorn
On Wednesday, Reuters reported that hedge funds overall have lost an average of 2% over the first half of the year, while the S&P gained around 6%. Below the average are unexpected names like John Paulson (flagship fund down 15%), David Einhorn (Greenlight Capital down 5%), and Bill Ackman (Pershing Square Capital down 2.27%). Read more...
» More Daniel Loeb Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Why Soros, Burbank and Cohen Bought this Fairly Valued Stock
In this article, let's take a look at Anheuser-Busch InBev SA/NV(BUD), a $184.78 billion market cap company that is a brewing company and manages a portfolio of over 200 brands of beer. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Different Hedge Fund Managers Bought and Added Molson Coors Brewing
In this article, let's take a look at Molson Coors Brewing Company (TAP), a $14.01 billion market cap company, which is the fifth largest brewer in the world, was formed in early 2005 via the combination of Adolph Coors Co. and Molson, Inc. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

The Broken-Leg Problem: Q&A with Abnormal Returns’ Tadas Viskanta about Deep Value Carl Icahn,Daniel Loeb - The Broken-Leg Problem: Q&A With Abnormal Returns’ Tadas Viskanta About Deep Value
Earlier this week I did a Q&A withAbnormal Returns’ Tadas Viskanta about Deep Value. Tadas sees more finance and investing content than anyone else, so it’s always interesting to see what he takes away from a topic: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb Comments on Sony Corp
In May of 2013, Third Point announced a significant stake in Sony (SNE) and suggested to the company’s CEO, Kazuo Hirai, that he should seriously consider spinning out 15‐20% of the company’s undervalued, American-based Entertainment business. At the time, we explained that partially listing the Entertainment segment would have three positive effects: 1) highlighting its profitability; 2) increasing investor transparency, thereby allowing the market to properly benchmark the company against its global media peers; and 3) incentivizing Entertainment’s management to run the company more efficiently by engaging in cost cutting and laying out clear earnings targets. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb Comments on Alibaba Group Holding Ltd
In our Quarterly Letter two and a half years ago, we argued “the Case for Alibaba.” At the time, Alibaba (BABA) held a leading market position that it was just beginning to monetize (the company had less than $75 million in LTM earnings). Today, the Company has continued its exponential growth, demonstrated significant margin leverage, and is expected to earn over $5 billion this fiscal year. Our enthusiasm for the Alibaba story has underpinned multiple investments at Third Point and now that the company is public, we have established a significant direct investment in Alibaba shares. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb Comments on eBay
We established a significant position in eBay (EBAY) during the Third Quarter. While eBay’s challenges were well‐mapped – including multiple years of minimal value growth, a weak execution track record, and high employee turnover – we sensed it had arrived at a critical inflection point and gained new focus. A meeting with CEO John Donahoe this summer left us impressed by his process‐driven approach to optimizing the business. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb Comments on Amgen Inc
Since its founding in 1980, Amgen (AMGN) (“the company”) has been a pioneer in the biotechnology industry, successfully discovering, developing, and marketing therapeutic agents that have meaningfully impacted human health. From 1989 to 2002, Amgen grew five revolutionary biologic drugs into billion dollar blockbuster products in oncology, nephrology, and inflammation. Today, Amgen is a $105 billion market cap company with annual revenues of nearly $20 billion and annual net income e of over $5billion. More...

  • Currently 4.40/5

Rating: 4.4/5 (5 votes)

Third Point Q3 2014 Investor Letter Daniel Loeb - Third Point Q3 2014 Investor Letter
This is the excerpt from the shareholder letter of Third Point Capital. More...

  • Currently 3.83/5

Rating: 3.8/5 (6 votes)

Invest In These Hedge Funds At A Discount David Einhorn, Daniel Loeb, Bill Ackman - Invest In These Hedge Funds At A Discount
As of the close on 10/13/2014, Greenlight Reinsurance (GLRE), Third Point Reinsurance (TPRE), and Pershing Square Holdings (AEX:PSH) were selling at discounted prices compared to their book values. These three companies are led by 3 of the top investing gurus we follow, David Einhorn, Daniel Loeb, and Bill Ackman. More...

Hedge, Hedge fund, Greenlight Reinsurance, Third Point Reinsurance, Pershing Square Holdings


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Dow Chemical´s Promising Future
In this article, let's take a look at The Dow Chemical Company (DOW), a $65.41 billion market cap company, which is the largest U.S. chemical company and provides chemical, plastic andagricultural products as well as services. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Daniel Loeb's New Stocks Daniel Loeb - Daniel Loeb's New Stocks
Dan Loeb is CEO of Third Point LLC, founded in 1995, where he oversees all investment activity. Third Point describes its underlying strategy as “event-driven, value-oriented,” and says it “seeks to identify situations where we anticipate a catalyst will unlock value,” on its website. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Hedge Fund Managers Are Buying Ally Financial Daniel Loeb,George Soros - Top Hedge Fund Managers Are Buying Ally Financial
Now that the investment management firms have filed their Form 13Fs with the SEC, we can gain better insight into which securities the investing gurus are buying and selling. The S&P 500 Grid at GuruFocus can be used to find the top buys, sells and net buys based on a number of different categories. More...

  • Currently 3.25/5

Rating: 3.3/5 (4 votes)

Which Is The Better Buy?: Einhorn's Greenlight Re or Loeb's Third Point Re Daniel Loeb - Which Is The Better Buy?: Einhorn's Greenlight Re Or Loeb's Third Point Re
Within the past week both Greenlight Re (GLRE) and Third Point Re (TPRE) released their second quarter earnings for 2014. The reinsurance companies both have investing gurus we follow running the investment portfolios. David Einhorn handles the portfolio for Greenlight Re, and Daniel Loeb is in charge of Third Point Re’s portfolio. Einhorn and Loeb started their long/short hedge funds in the mid-1990s and have had annual gains of about 20 percent each since inception. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Global Market Valuations And Expected Returns - August 6, 2014 Daniel Loeb - Global Market Valuations And Expected Returns - August 6, 2014
In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after the excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. In April, it was about even for the whole month. In May, the market gained 2.10% and in June, the market benchmark S&P 500 went up 1.91%. However, in July, the market went down by 1.51%. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Third Point Comments on Royal DSM NV
Over the past three years, Royal DSM NV (“DSM”) has transformed itself into a leading global life sciences company focused on health and nutrition with ~$12 billion of sales and ~$1.7 billion of EBITDA. DSM’s portfolio of businesses also includes legacy activities in materials sciences. While the Materials segments account for ~55% of sales, their profit contribution to the DSM group (~30% of EBITDA) has been greatly surpassed by that of the Nutrition segment (~70% of EBITDA). Earlier this year, DSM shares sold-off following: i) a profit warning in the Nutrition segment, and ii) growing skepticism about DSM’s ability to execute on its plan to divest its commodity caprolactam business. The weakness in DSM’s share price served as an opportunity to build our position. We believe that the profit warning in Nutrition was driven by cyclical factors and abnormally adverse weather rather than any structural changes in the underlying fundamentals. We are also optimistic that management can successfully separate its commodity caprolactam exposure through either a sale or joint venture. Finally, near-term trends are positive More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb’s Third Point Second Quarter 2014 Investor Letter
Review and Outlook More...

  • Currently 2.40/5

Rating: 2.4/5 (5 votes)

Einhorn Is Transforming BioFuel Energy Into A Profitable Real Estate Company Daniel Loeb - Einhorn Is Transforming BioFuel Energy Into A Profitable Real Estate Company
Two of the gurus that I follow at GuruFocus are David Einhorn and Daniel Loeb. They are both considered to be activist investors and their hedge funds have experienced extraordinary results. Loeb started Third Point Capital in 1995 and Einhorn started Greenlight Capital in 1996. Third Point Capital has returned 20.4 percent annulized since its inception in 1995, and Greenlight Capital has returned 19.5 percent annualized since May of 1996. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Insider Sells Highlight: Cytec Industries Inc.
Vice President and CFO of Cytec Industries Inc. (CYT) David Drillock sold 49,038 shares on July 21 at an average price of $107.06. The total transaction amount was $5,250,008. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Insider Sells Highlight: Google Inc.
CEO and 10% Owner of Google Inc (GOOG) Lawrence Page sold 33,332 shares on July 14 at an average price of $586.48. The total transaction amount is $19,548,551. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Guardinvest
ReplyGuardinvest - 1 month ago
Following DOW as he puts added pressure on them to split and divest their commodity chemical business as well as increase stock buy backs. Creating a Shadow Board.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK